Vaishali Pharma Limited (VAISHALI)

20.2

INR
+1.67(+9.01%)
As of December 6, 2024 9:59:00 AM

Vaishali Pharma Limited Share Price Information

24 hour Low and High

Low: 18.17
High: 20.3

All time High

4038.03

Price Change 1h

+₹0.92 +4.77%

Price Change 1d

+₹0.92 +4.77%

Price Change 1w

+₹3.64 +21.98%

Vaishali Pharma Limited Market Information

Exchange

NSE

Market Cap

235.74 Cr

About Vaishali Pharma Limited Share

Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers active pharmaceutical ingredients (APIs), including antibiotics, anti-ulcer, anti-inflammatory/analgesic/anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, anti-diarrheal/anti-protozoal/anti-parasitic, anti-viral, anti-epileptic, anti-asthmatic, anti-fungal, anti-platelet agent, skeletal muscle relaxant, and anti-helmintic drugs, as well as excipients, topical steroids, corticosteroids, and enzymes. The company also provides formulation products, such as antibiotics/antibacterial, anti platelet, laxative, anti-ulcer/enzyme, anti-asthmatic, anti malarial, anti-cold/anti-allergic/anti-viral, anti-psychotic, cardiac, anti-diabetic, anti-inflamatory/ananlgesic/anti-pyretic, topical steroids/corticosteroids, anti-fungal, vitamins, and other formulations. In addition, it offers veterinary, nutraceutical, oncology, herbal, and surgical products. The company was formerly known as Vaishali Pharma Private Limited. Vaishali Pharma Limited was founded in 1989 and is based in Mumbai, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

27

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Vaishali Pharma Ltd Fixes Record Date for 1:1 Bonus Issue and 1:5 Stock Split; Expects to continue its Strong Growth Momentum with Innovation
  • Vaishali Pharma announces bonus issue, stock split. Shares up 10%
  • Vaishali Pharma's Stock Price Reaches All-Time High, Outperforms Sector and Market
  • Vaishali Pharma fixes record date for 1:1 bonus issue & 1:5 stock split, expects to continue strong gro...
  • Vaishali Pharma Limited Reports Earnings Results for the Half Year Ended September 30, 2019

FAQs

Vaishali Pharma Limited (VAISHALI)

20.2

INR
+1.67(+9.01%)
As of December 6, 2024 9:59:00 AM

Vaishali Pharma Limited Share Price Information

24 hour Low and High

Low: 18.17
High: 20.3

All time High

4038.03

Price Change 1h

+₹0.92 +4.77%

Price Change 1d

+₹0.92 +4.77%

Price Change 1w

+₹3.64 +21.98%

Vaishali Pharma Limited Market Information

Exchange

NSE

Market Cap

235.74 Cr

About Vaishali Pharma Limited Share

Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers active pharmaceutical ingredients (APIs), including antibiotics, anti-ulcer, anti-inflammatory/analgesic/anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, anti-diarrheal/anti-protozoal/anti-parasitic, anti-viral, anti-epileptic, anti-asthmatic, anti-fungal, anti-platelet agent, skeletal muscle relaxant, and anti-helmintic drugs, as well as excipients, topical steroids, corticosteroids, and enzymes. The company also provides formulation products, such as antibiotics/antibacterial, anti platelet, laxative, anti-ulcer/enzyme, anti-asthmatic, anti malarial, anti-cold/anti-allergic/anti-viral, anti-psychotic, cardiac, anti-diabetic, anti-inflamatory/ananlgesic/anti-pyretic, topical steroids/corticosteroids, anti-fungal, vitamins, and other formulations. In addition, it offers veterinary, nutraceutical, oncology, herbal, and surgical products. The company was formerly known as Vaishali Pharma Private Limited. Vaishali Pharma Limited was founded in 1989 and is based in Mumbai, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

27

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Vaishali Pharma Ltd Fixes Record Date for 1:1 Bonus Issue and 1:5 Stock Split; Expects to continue its Strong Growth Momentum with Innovation
  • Vaishali Pharma announces bonus issue, stock split. Shares up 10%
  • Vaishali Pharma's Stock Price Reaches All-Time High, Outperforms Sector and Market
  • Vaishali Pharma fixes record date for 1:1 bonus issue & 1:5 stock split, expects to continue strong gro...
  • Vaishali Pharma Limited Reports Earnings Results for the Half Year Ended September 30, 2019

FAQs